Universal Detection Technology (OTCBB: UNDT)   Universal Detection Technology has licensed a spore detection technology from NASA's Jet Propulsion Laboratory (JPL) and has developed a first of its kind real-time continuous detection device capable of identifying abnormal levels of bacterial spores in the air, an indication of a possible anthrax attack.

Recent Price $.004 Market Capitalization $3.8 M Est. Float N/A Outstanding Shares 950 M Exchange OTCBB Universal Detection Technology 9595 Wilshire Blvd. Suite 700 Beverly Hills, CA 90212 http://www.udetection.com

Similar Companies in Sector • Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represent about 78% of the company's 2008 revenue of $3.1 billion. NYSE: BEC $66.94 • Camtek Ltd. headquarters in Migdal Ha'Emek Israel, Camtek Ltd., designs, develops, manufactures, and markets automatic optical inspection systems and related products. Camtek's automatic inspection systems are used to enhance both production processes and yield for manufacturers in the printed circuit board industry, the high density interconnect substrate industry and the semiconductor manufacturing and packaging industry. NASDAQ: CAMT $1.39

Universal Detection Technology recently announced that its partner in the development of border and zone security sensors, Precision Sensors Instrumentation (PSI), has reported field test results for its position sensor system. The field test results, conducted at an air force base, provided irrefutable and comparative data showing the discriminating advantage of the technology. The sensor was able to discern between human and vehicle traffic well in advance of the perimeter of the airbase, positioning it as an optimal sensor to use for border protection.

Universal Detection Technology Reports Outcome of Exhibiting at the Milipol Exposition in Paris, and the Terrorism and Security Conference in London UNDT showcased the latest developments in bio-weapons detection technology, including the company's TS-10-5, a five-agent biodetection handheld assay, at the 2009 Milipol Conference. The biodetection kits were well received by the conference attendees, including officials from military and civil forces from around the globe. UNDT was also able to establish contact with international companies interested in representing the company and its products in their respective countries.

Universal Detection Technology (UNDT) Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. For more information, please visit www.udetection.com. Universal Detection Technology has licensed a spore detection technology from NASA's Jet Propulsion Laboratory (JPL) and has developed a first of its kind real-time continuous detection device capable of identifying abnormal levels of bacterial spores in the air, an indication of a possible anthrax attack. The Company constantly seeks to license new technologies based on which it can transform cutting edge science into tangible and everyday products. Additionally, the Company offers its expert advice to customers with regards to a variety of subjects including post and pre incident planning, bio-terror detection for large events, and drafting customized security plans for customers interested in taking a proactive approach against bio-terrorism. Products : BSM-2000;Autonomous Anthrax Detector UDT's device, developed in collaboration with JPL, functions as a first line of defense against a biological attack with anthrax spores. The device continuously samples the air and uses heat to "pop" the spores thus releasing a chemical from within the bacterial spore, called dipicolinic acid (DPA). This molecule is unique to bacterial spores. Radiation Detection Bioterrorism Detection  Homeland Security Detection Devices  Electronic Dosimeters   Instant Radiation Exposure Detection      Test Kits    Test Strips  Simulation Dust Leadership Mr. JACQUES TIZABI, Chairman and Chief Executive Officer Mr. Tizabi is a frequent public speaker and an advisor/board member to numerous private and public companies in sectors ranging from medical device and information technologies to diversified entertainment and international business development. Mr. Tizabi has participated in several political campaigns on the local, state and federal levels. He holds a B.S. from New York University 's Stern School of Business and an MBA from Pepperdine University. Mr. AMIR ETTEHADIEH, Research & Development As the scientific liaison between UDTT and NASA's Jet Propulsion Laboratory, Mr. Ettehadieh plays an instrumental role in the development of the Company's bio-detection device. Prior to joining UDTT, he was an environmental scientist at EMG, an environmental consulting firm based in Baltimore . Mr. Ettehadieh conducted site inspections on over 150 hazardous material sites, assessing potential health impacts of pollutants in the air, water and soil. He holds a B.A in Biology. Dr. LOUIS J. IGNARRO, Chairman of Scientific Advisory Board Dr. Ignarro has made exceptional contributions to the advancement of science, including winning the Nobel † Prize for Physiology or Medicine in 1998 for his research on nitric oxide. His work has led and inspired scientists around the world. A Distinguished Professor of Pharmacology, UCLA School of Medicine, Dr. Ignarro served as Professor of Pharmacology at Tulane University School of Medicine, New Orleans . Before teaching, he served as a scientist at CIBA-GEIGY. Dr. Ignarro has published many articles and received the Basic Research Prize of the American Heart Association for outstanding contributions to the advancement of cardiovascular science. He was inducted into the National Academy of Sciences the same year, and into the American Academy of Arts and Sciences the next year. Dr. Ignarro holds a B.S. in Pharmacology, Columbia University , 1962, and a Ph.D. in Pharmacology, University of Minnesota , 1966. He received his Postdoctoral Fellowship from the National Institutes of Health, 1968. †The Nobel Prize is a registered trademark of the Nobel Foundation. LEONARD MAKOWKA, M.D., Ph.D., FRCS(C), FACS, Member of Scientific Advisory Board Dr. Makowka is recognized as one of the world's leading authorities in hepatic science (study relating to the liver). In addition to his clinical accomplishments, he has successfully served in numerous executive positions. From 1995 to 1997, Dr. Makowka was the founder and Executive Director of the Comprehensive Liver Disease and Treatment Center at St. Vincent Medical Center in Los Angeles , California . Between 1989 and 1995, Dr. Makowka was the Chairman of the Department of Surgery and Director of Transplantation Services at Cedars-Sinai Medical Center in Los Angeles , California . He was also Professor of Surgery at the UCLA School of Medicine. Beginning in 1985 until relocating to Los Angeles in 1989, Dr. Makowka trained under Dr. Thomas Starzl, the pioneer of liver transplantation, and was appointed Associated Professor in the Department of Surgery at the University of Pittsburgh . Dr. Makowka received his MD degree from the University of Toronto Medical School in 1977, and Master of Science and Doctorate of Philosophy from the University of Toronto 's Department of Pathology in 1979 and 1982. He has published over 400 articles and chapters in both clinical and basic scientific research and has lectured worldwide. As one of the world's leading authorities in his field, Dr. Makowka has performed hundreds of hepatobiliary and liver transplant procedures. INVENTOR Dr. ADRIAN PONCE, NASA JPL Dr. Ponce, California Institute of Technology's (CALTECH) visiting associate in Chemistry and Senior Technical Staff Member at JPL, currently resides as Chairman of the JPL Chemical Safety Committee and is an active member of the JPL Science Advisory Council. He received a Ph.D. in Chemistry from California Institute of Technology in 1999 and a B.S. in Chemistry from Michigan State University in 1993. His Research interests include Molecular and Mesoscale Self-Assembly, Electron Transfer, Laser Spectroscopy, Chemical and Biological Sensors.

PLEASE NOTE: First Alert Stocks and/or its affiliates are not registered as Investment Advisors in any jurisdiction whatsoever.

Release of Liability: Through use of First Alert Stocks email newsletters and website you agree to hold First Alert Stocks, its operators, owners, and employees harmless and completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. First Alert Stocks The owner, publisher, editor and their associates are not responsible for errors and omissions. First Alert Stocks and/or its affiliates may from time to time have positions in the securities mentioned herein, may increase or decrease such positions without notice, and may profit from such transactions. First Alert Stocks encourages readers and investors to supplement the information in these reports with independent research and other professional advice.

Privacy Statement

Discover the Secrets to
"Investing in Stocks"

Free Trader EBook Library

Master Your Trading Mindtraps

Tips and Tricks For a Trader to Make the Market Work For You

When To Sell Stocks